These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30744517)

  • 1. The Hawthorne effect as a pre-placebo expectation in Parkinsons disease patients participating in a randomized placebo-controlled clinical study.
    Morberg BM; Malling AS; Jensen BR; Gredal O; Wermuth L; Bech P
    Nord J Psychiatry; 2018 Aug; 72(6):442-446. PubMed ID: 30744517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of transcranial pulsed electromagnetic fields (T-PEMF) on functional rate of force development and movement speed in persons with Parkinson's disease: A randomized clinical trial.
    Malling ASB; Morberg BM; Wermuth L; Gredal O; Bech P; Jensen BR
    PLoS One; 2018; 13(9):e0204478. PubMed ID: 30252895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of transcranial pulsed electromagnetic field stimulation on quality of life in Parkinson's disease.
    Morberg BM; Malling AS; Jensen BR; Gredal O; Bech P; Wermuth L
    Eur J Neurol; 2018 Jul; 25(7):963-e74. PubMed ID: 29573167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
    Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C
    Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Frequency Repetitive Transcranial Magnetic Stimulation Can Improve Depression in Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Study.
    Makkos A; Pál E; Aschermann Z; Janszky J; Balázs É; Takács K; Karádi K; Komoly S; Kovács N
    Neuropsychobiology; 2016; 73(3):169-77. PubMed ID: 27093063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
    Barone P; Poewe W; Albrecht S; Debieuvre C; Massey D; Rascol O; Tolosa E; Weintraub D
    Lancet Neurol; 2010 Jun; 9(6):573-80. PubMed ID: 20452823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non-motor symptoms - results of a double-blind, randomized, placebo-controlled trial.
    Antonini A; Bauer L; Dohin E; Oertel WH; Rascol O; Reichmann H; Schmid M; Singh P; Tolosa E; Chaudhuri KR
    Eur J Neurol; 2015 Oct; 22(10):1400-7. PubMed ID: 26095948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind trial of transcranial electrostimulation in early Parkinson's disease.
    Shill HA; Obradov S; Katsnelson Y; Pizinger R
    Mov Disord; 2011 Jul; 26(8):1477-80. PubMed ID: 21538515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: a randomized, double-blind, placebo-controlled study.
    Pal E; Nagy F; Aschermann Z; Balazs E; Kovacs N
    Mov Disord; 2010 Oct; 25(14):2311-7. PubMed ID: 20740485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's disease and transcranial pulsed electromagnetic fields: A randomized clinical trial.
    Morberg BM; Malling AS; Jensen BR; Gredal O; Bech P; Wermuth L
    Mov Disord; 2017 Apr; 32(4):625-626. PubMed ID: 28116825
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies.
    Leentjens AF; Koester J; Fruh B; Shephard DT; Barone P; Houben JJ
    Clin Ther; 2009 Jan; 31(1):89-98. PubMed ID: 19243709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of cumulative high-frequency rTMS on freezing of gait in Parkinson's disease.
    Kim MS; Chang WH; Cho JW; Youn J; Kim YK; Kim SW; Kim YH
    Restor Neurol Neurosci; 2015; 33(4):521-30. PubMed ID: 26409410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes.
    Rascol O; Fitzer-Attas CJ; Hauser R; Jankovic J; Lang A; Langston JW; Melamed E; Poewe W; Stocchi F; Tolosa E; Eyal E; Weiss YM; Olanow CW
    Lancet Neurol; 2011 May; 10(5):415-23. PubMed ID: 21482191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-frequency rTMS over the supplementary motor area for treatment of Parkinson's disease.
    Hamada M; Ugawa Y; Tsuji S;
    Mov Disord; 2008 Aug; 23(11):1524-31. PubMed ID: 18548577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial.
    NINDS Exploratory Trials in Parkinson Disease (NET-PD) FS-ZONE Investigators
    Lancet Neurol; 2015 Aug; 14(8):795-803. PubMed ID: 26116315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.
    Smith KM; Eyal E; Weintraub D;
    JAMA Neurol; 2015 Jan; 72(1):88-95. PubMed ID: 25420207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repetitive Deep TMS for Parkinson Disease: A 3-Month Double-Blind, Randomized Sham-Controlled Study.
    Cohen OS; Rigbi A; Yahalom G; Warman-Alaluf N; Nitsan Z; Zangen A; Hassin-Baer S
    J Clin Neurophysiol; 2018 Mar; 35(2):159-165. PubMed ID: 29373395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does levodopa slow or hasten the rate of progression of Parkinson's disease?
    Fahn S;
    J Neurol; 2005 Oct; 252 Suppl 4():IV37-IV42. PubMed ID: 16222436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The optimal stimulation site for high-frequency repetitive transcranial magnetic stimulation in Parkinson's disease: A double-blind crossover pilot study.
    Yokoe M; Mano T; Maruo T; Hosomi K; Shimokawa T; Kishima H; Oshino S; Morris S; Kageyama Y; Goto Y; Shimizu T; Mochizuki H; Yoshimine T; Saitoh Y
    J Clin Neurosci; 2018 Jan; 47():72-78. PubMed ID: 29054329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.